Position in BIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$143,989,865
+$19,958,103 QoQ
Shares Held
490,412
+10.2% QoQ
Ownership
1.83%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 397 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Derivatives in BIO
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$906,684
PutShares
1,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $7,730,553,510 across 90 Medical Devices names. BIO ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
21,322,401 | $1,668,051,425 | |
| 2 | ABT |
Abbott Laboratories
|
17,672,543 | $1,603,606,548 | |
| 3 | SYK |
Stryker Corp
|
4,460,311 | $1,404,284,312 | |
| 4 | EW |
Edwards Lifesciences Corp
|
6,692,424 | $605,396,672 | |
| 5 | BSX |
Boston Scientific Corp
|
13,027,783 | $556,025,776 | |
| 6 | DXCM |
Dexcom Inc
|
3,163,604 | $213,068,725 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,249,771 | $208,017,839 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
2,177,724 | $187,480,255 |
All Filings in BIO
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,989,865 | 490,412 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $124,031,762 | 444,957 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $134,966,589 | 445,449 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $109,108,732 | 452,133 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $104,862,075 | 430,539 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $140,369,691 | 427,292 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $140,192,030 | 419,009 | Shares | Defined | 2025-03-18 | |
| 2024-06-30 | $120,680,750 | 441,876 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $119,175,733 | 344,568 | Shares | Defined | 2025-03-18 | |
| 2023-12-31 | $125,214,477 | 387,793 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $178,019,887 | 496,638 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $169,639,893 | 447,457 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $220,452,185 | 460,215 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $171,894,626 | 408,796 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $171,054,927 | 410,066 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $201,758,040 | 407,592 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $222,193,669 | 394,499 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 BIO-B | — | 38 | Shares | Defined | 2022-02-08 | |
| 2021-12-31 | $280,052,773 | 370,651 | Shares | Defined | 2022-02-08 | |
| 2021-12-31 | $906,684 | 1,200 | Put | Defined | 2022-02-08 | |
| 2021-09-30 BIO-B | $28,876 | 38 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $285,005,858 | 382,071 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $211,767,558 | 370,761 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $212,829,059 | 365,096 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $198,010,863 | 384,144 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 BIO-B | $2,184 | 5 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $157,290,083 | 348,380 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 BIO-B | $1,756 | 5 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $120,078,365 | 342,533 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||